首页> 外文期刊>Anesthesia and pain medicine. >?? ??? ?? ???: ??, ??, ??
【24h】

?? ??? ?? ???: ??, ??, ??

机译:?? ??? ?? ???: ??, ??, ??

获取原文
           

摘要

Kidney transplantation is one of the treatments for the end-stage renal disease for various reasons. Ischemia-reperfusion injury (IRI) is an important mechanism of injury associated with acute rejection, delayed graft function, late graft failure, and graft loss in renal transplantation. Ischemic conditioning, which applies brief ischemia and reperfusion before, during, or after IRI is one of the protecting IRI strategies. Although animal studies have demonstrated the efficacy of IRI, the translation into beneficial clinical outcomes to humans is still controversial. By investigating the usefulness of ischemic conditioning in kidney transplantation in the present work, we aim to review overall ischemic conditioning and desire to predict the future of ischemic conditioning.
机译:由于各种原因,肾脏移植是终末期肾脏疾病的治疗方法之一。缺血再灌注损伤(IRI)是与急性排斥反应,移植物功能延迟,移植物晚期衰竭和肾移植中移植物丢失相关的重要损伤机制。在IRI之前,之中或之后进行短暂缺血和再灌注的缺血性调节是IRI保护策略之一。尽管动物研究证明了IRI的功效,但对人类有益的临床结果的转化仍存在争议。通过研究当前工作中缺血性调理在肾脏移植中的有用性,我们旨在综述整体缺血性调理,并希望预测缺血性调理的未来。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号